BIOMAT Database Logo BIOMAT Database Logo

Changes in left atrial function, left ventricle remodeling, and fibrosis after septal myectomy for obstructive hypertrophic cardiomyopathy. 2022

Bing Tang, and Yunhu Song, and Qiulan Yang, and Hao Cui, and Keshan Ji, and Shihua Zhao, and Shuiyun Wang
Department of Cardiac Surgery, Beijing Aortic Disease Center, Beijing Anzhen Hospital, Capital Medical University & Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China; Department of Cardiac Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

This study aimed to investigate the impact of septal myectomy on left atrial function, left ventricle remodeling, and fibrosis in patients with obstructive hypertrophic cardiomyopathy. From May 2012 to September 2016, preoperative cardiac magnetic resonance imaging of 507 adult patients who underwent septal myectomy at Fuwai Hospital was retrospectively collected. Until October 2019, 57 patients were followed up with postoperative cardiac magnetic resonance imaging at 11.9 months (interquartile range, 6.4-25.3). Preoperative and postoperative left atrium and left ventricle changes, as well as late gadolinium enhancement as a surrogate of myocardial fibrosis, were analyzed. Patients with hypertrophic cardiomyopathy requiring myectomy showed increased left atrium volume, stroke volume, left ventricular ejection fraction, and left ventricle mass, as well as decreased left ventricle end-systolic volume. Echocardiography demonstrated that myectomy decreased the left ventricle outflow tract gradient, left atrium diameter, left ventricular ejection fraction, and posterior wall thickness. Postoperative cardiac magnetic resonance imaging showed that the minimal left atrium volume (P < .001), stroke volume (P = .009), left ventricle ejection fraction (P < .001), and left ventricle mass (166.9 [interquartile range, 135.8] vs 149.3 [interquartile range, 100.5] g, P < .001) decreased, whereas the left ventricle end-systolic volume (P = .001) and left atrium ejection fraction (37.9% ± 14.6% vs 47.8% ± 14%, P < .001) increased. However, left ventricle myocardial fibrosis, as detected by late gadolinium enhancement, still progressed after myectomy in patients with obstructive hypertrophic cardiomyopathy (15.2% ± 9.6% vs 18.6% [interquartile range, 21.6], P = .009). Septal myectomy alleviated left ventricle hypertrophy and reversed left atrium and left ventricle remodeling in patients with obstructive hypertrophic cardiomyopathy. Late gadolinium enhancement in the left ventricle increased despite myectomy in patients with obstructive hypertrophic cardiomyopathy.

UI MeSH Term Description Entries
D002312 Cardiomyopathy, Hypertrophic A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY). Cardiomyopathy, Hypertrophic Obstructive,Cardiomyopathies, Hypertrophic,Cardiomyopathies, Hypertrophic Obstructive,Hypertrophic Cardiomyopathies,Hypertrophic Cardiomyopathy,Hypertrophic Obstructive Cardiomyopathies,Hypertrophic Obstructive Cardiomyopathy,Obstructive Cardiomyopathies, Hypertrophic,Obstructive Cardiomyopathy, Hypertrophic
D003287 Contrast Media Substances used to allow enhanced visualization of tissues. Radiopaque Media,Contrast Agent,Contrast Agents,Contrast Material,Contrast Materials,Radiocontrast Agent,Radiocontrast Agents,Radiocontrast Media,Agent, Contrast,Agent, Radiocontrast,Agents, Contrast,Agents, Radiocontrast,Material, Contrast,Materials, Contrast,Media, Contrast,Media, Radiocontrast,Media, Radiopaque
D005355 Fibrosis Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury. Cirrhosis,Fibroses
D005682 Gadolinium An element of the rare earth family of metals. It has the atomic symbol Gd, atomic number 64, and atomic weight 157.25. Its oxide is used in the control rods of some nuclear reactors.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D013318 Stroke Volume The amount of BLOOD pumped out of the HEART per beat, not to be confused with cardiac output (volume/time). It is calculated as the difference between the end-diastolic volume and the end-systolic volume. Ventricular Ejection Fraction,Ventricular End-Diastolic Volume,Ventricular End-Systolic Volume,Ejection Fraction, Ventricular,Ejection Fractions, Ventricular,End-Diastolic Volume, Ventricular,End-Diastolic Volumes, Ventricular,End-Systolic Volume, Ventricular,End-Systolic Volumes, Ventricular,Fraction, Ventricular Ejection,Fractions, Ventricular Ejection,Stroke Volumes,Ventricular Ejection Fractions,Ventricular End Diastolic Volume,Ventricular End Systolic Volume,Ventricular End-Diastolic Volumes,Ventricular End-Systolic Volumes,Volume, Stroke,Volume, Ventricular End-Diastolic,Volume, Ventricular End-Systolic,Volumes, Stroke,Volumes, Ventricular End-Diastolic,Volumes, Ventricular End-Systolic
D016277 Ventricular Function, Left The hemodynamic and electrophysiological action of the left HEART VENTRICLE. Its measurement is an important aspect of the clinical evaluation of patients with heart disease to determine the effects of the disease on cardiac performance. Left Ventricular Function,Function, Left Ventricular,Functions, Left Ventricular,Left Ventricular Functions,Ventricular Functions, Left
D016279 Atrial Function, Left The hemodynamic and electrophysiological action of the LEFT ATRIUM. Left Atrial Function,Atrial Functions, Left,Function, Left Atrial,Functions, Left Atrial,Left Atrial Functions

Related Publications

Bing Tang, and Yunhu Song, and Qiulan Yang, and Hao Cui, and Keshan Ji, and Shihua Zhao, and Shuiyun Wang
Left ventricular remodeling following septal myectomy in hypertrophic obstructive cardiomyopathy.
September 2022, JTCVS open,
Bing Tang, and Yunhu Song, and Qiulan Yang, and Hao Cui, and Keshan Ji, and Shihua Zhao, and Shuiyun Wang
Effects of septal myectomy on left atrial and left ventricular function in obstructive hypertrophic cardiomyopathy.
October 2023, ESC heart failure,
Bing Tang, and Yunhu Song, and Qiulan Yang, and Hao Cui, and Keshan Ji, and Shihua Zhao, and Shuiyun Wang
Myocardial mechanical remodeling after septal myectomy for severe obstructive hypertrophic cardiomyopathy.
August 2013, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography,
Bing Tang, and Yunhu Song, and Qiulan Yang, and Hao Cui, and Keshan Ji, and Shihua Zhao, and Shuiyun Wang
Septal myectomy for obstructive hypertrophic cardiomyopathy.
January 2005, Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual,
Bing Tang, and Yunhu Song, and Qiulan Yang, and Hao Cui, and Keshan Ji, and Shihua Zhao, and Shuiyun Wang
Spontaneous closure of iatrogenic coronary artery fistula to left ventricle after septal myectomy for hypertrophic obstructive cardiomyopathy.
December 2006, Journal of Korean medical science,
Bing Tang, and Yunhu Song, and Qiulan Yang, and Hao Cui, and Keshan Ji, and Shihua Zhao, and Shuiyun Wang
Transmitral Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy.
April 2018, The Annals of thoracic surgery,
Bing Tang, and Yunhu Song, and Qiulan Yang, and Hao Cui, and Keshan Ji, and Shihua Zhao, and Shuiyun Wang
Perioperative Amiodarone to Prevent Atrial fibrillation after Septal Myectomy in obstrUctive hypeRtroPHic cardiomyopathy.
December 2021, ESC heart failure,
Bing Tang, and Yunhu Song, and Qiulan Yang, and Hao Cui, and Keshan Ji, and Shihua Zhao, and Shuiyun Wang
Long-lasting improvement after septal myectomy for hypertrophic obstructive cardiomyopathy.
June 2000, The Annals of thoracic surgery,
Bing Tang, and Yunhu Song, and Qiulan Yang, and Hao Cui, and Keshan Ji, and Shihua Zhao, and Shuiyun Wang
Patient-Reported Atrial Fibrillation After Septal Myectomy for Hypertrophic Cardiomyopathy.
June 2022, The Annals of thoracic surgery,
Bing Tang, and Yunhu Song, and Qiulan Yang, and Hao Cui, and Keshan Ji, and Shihua Zhao, and Shuiyun Wang
Minimally Invasive Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy.
January 2017, Innovations (Philadelphia, Pa.),
Copied contents to your clipboard!